Skip to main content
Premium Trial:

Request an Annual Quote

Australia Invests A$500M in Medical Genomics Research to Improve Patient Care

NEW YORK (GenomeWeb) – The Australian government has announced that it will invest A$500 million (US$372 million) in genomics as part of its 2018-2019 Health Budget.

Known as the Australian Genomics Health Futures Mission, the program is part of a broader A$1.3 billion national Health and Medical Industry Growth Plan aimed at improving health outcomes of more than 200,000 Australians, according to Australia Minister for Health Greg Hunt.

The mission will include a series of studies to tackle rare diseases and cancers, clinical trials to allow patients early access to test drugs, co-investing with philanthropic and business interests, and a community dialogue to understand the privacy, legal, social, and familial impacts of genomic medicine.

The mission's first genomics project — known as Mackenzie's Mission — will use A$20 million for a preconception screening trial for rare and debilitating birth disorders, including spinal muscular atrophy, fragile X syndrome, and cystic fibrosis.

According to Hunt, the government will also use A$240 million to form the Frontier Science program, which will develop new medical ideas, research, devices, and treatments. In addition, it will establish the A$125 million Targeted Translation Research Accelerator to focus on diabetes and cardiac disease.

The Scan

Positive Framing of Genetic Studies Can Spark Mistrust Among Underrepresented Groups

Researchers in Human Genetics and Genomics Advances report that how researchers describe genomic studies may alienate potential participants.

Small Study of Gene Editing to Treat Sickle Cell Disease

In a Novartis-sponsored study in the New England Journal of Medicine, researchers found that a CRISPR-Cas9-based treatment targeting promoters of genes encoding fetal hemoglobin could reduce disease symptoms.

Gut Microbiome Changes Appear in Infants Before They Develop Eczema, Study Finds

Researchers report in mSystems that infants experienced an enrichment in Clostridium sensu stricto 1 and Finegoldia and a depletion of Bacteroides before developing eczema.

Acute Myeloid Leukemia Treatment Specificity Enhanced With Stem Cell Editing

A study in Nature suggests epitope editing in donor stem cells prior to bone marrow transplants can stave off toxicity when targeting acute myeloid leukemia with immunotherapy.